SecuringPharma - Pharmaceutical anti-counterfeiting news

News headlines:

Manage subscription Reset Password

IQPC EU Pharmaceutical Anti-Counterfeiting

FDA tightens border controls for drugs and food

FDA Commissioner Margaret Hamburg has announced new border screening initiative - PREDICT - designed to prevent contaminated food and medicines from entering the USA.

Other News

GSK and eBay team up to fight fake Alli
GlaxoSmithKline has joined forces with eBay to try to remove online auctions peddling fake versions of its Alli weight loss drug.
Cutting out the middleman: the rise of direct distribution in pharma
A new trend in the US pharmaceutical sector, restricted distribution, is providing new opportunities to companies providing technologies that track goods from the manufacturer to the consumer.
EFPIA updates on Swedish serialisation project at Pharmapack
The pharmaceutical serialisation pilot currently ongoing in Sweden is progressing smoothly, said EFPIA's Jean-Marc Bobée at this week's Pharmapack exhibition.
Management shuffle at T Ray Science
The chief technology officer of Canadian company T Ray Sciences, Dr. Daryoosh Saeedkia, has left the company. No reasons were given for Saeedkia's departure.
Turkish serialisation project misses yet another deadline
Turkey has missed its January 1 deadline for a serialised coding system for medicines because pharmacies have not implemented the system in time.
EMA 'road map' outlines supply chain security plans
The latest five-year plan from the EMA makes specific reference to a number of supply chain security elements, with a greater emphasis on counterfeiting and substandard ingredients than earlier documents.

News in brief

Cutting out the middleman: the rise of direct distribution in pharma
A new trend in the US pharmaceutical sector, restricted distribution, is providing new opportunities to companies providing technologies that track goods from the manufacturer to the consumer.
Parliamentary report broadens, accelerates counterfeiting directive
The European Parliamentary report on the proposed counterfeit directive is now in circulation, with the author, MEP Marisa Matias, putting forward a number of amendments that widen its scope.
PGEU wants robust debate on safety features
There needs to be a “robust” debate about the type of safety features to be applied under the European Commission’s draft directive on counterfeit medicines, says PGEU chief John Chave.